Atlas Trials

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Clinical trial NCT04436510 · COMPLETED

Trial details

NCT number
NCT04436510
Sponsor
Merit E. Cudkowicz, MD
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2020-07-28
Primary completion
2022-04-13
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.